Novo Nordisk Said to Have Contracted Ypsomed to Make Next Gen Obesity Drug's Pens

Seeking Alpha15minutes ago

Amgen (AMGN.US) weight loss drug is poised to launch, and Wall Street is eagerly awaiting the research results.

Amgen (AMGN.US) will soon release mid-term study data for the experimental weight loss drug MariTide, revealing a comparison of this drug with GLP-1 drugs from Eli Lilly (LLY.US) and novo-nordisk A/S (NVO.US).

Zhitong Finance04:02 ET

In 2025, the global medical care industry is expected to usher in an investment boom, with a focus on Biotech.

Jefferies financial indicated that investor sentiment in the global medical care industry has significantly warmed up.

Zhitong Finance20:21 ET

Optimism Over Global Healthcare Sector Rises: Jefferies

Seeking Alpha13:45 ET

Eli Lilly Stock Tumbles As Kennedy Targets Weight Loss Drugs

Benzinga12:47 ET

European Equities Traded in the US as American Depositary Receipts Edge Lower Thursday

MT Newswires11:20 ET